Le informazioni sugli articoli di fonte ISI sono coperte da copyright

Per ulteriori informazioni selezionare i riferimenti di interesse.

1. White, WB; Elliott, WJ; Johnson, MF; Black, HR
   Chronotherapeutic delivery of verapamil in obese versus non-obese patientswith essential hypertension
   JOURNAL OF HUMAN HYPERTENSION
   
   W.B. White et al., "Chronotherapeutic delivery of verapamil in obese versus non-obese patientswith essential hypertension", J HUM HYPER, 15(2), 2001, pp. 135-141
2. Black, HR; Elliott, WJ; Weber, MA; Frishman, WH; Strom, JA; Liebson, PR; Hwang, CT; Ruff, DA; Montoro, R; DeQuattro, V; Zhang, DY; Schleman, MM; Klibaner, MI
   One-year study of felodipine or placebo for stage 1 isolated systolic hypertension
   HYPERTENSION
   
   H.R. Black et al., "One-year study of felodipine or placebo for stage 1 isolated systolic hypertension", HYPERTENSIO, 38(5), 2001, pp. 1118-1123
3. Epstein, M; Black, HR
   Arterial calcification and calcium antagonists - What does it mean?
   HYPERTENSION
   
   M. Epstein e H.R. Black, "Arterial calcification and calcium antagonists - What does it mean?", HYPERTENSIO, 37(6), 2001, pp. 1414-1415
4. Black, HR; Elliott, WJ; Neaton, JD; Grandits, G; Grambsch, P; Grimm, RH; Hansson, L; Lacouciere, Y; Muller, J; Sleight, P; Weber, MA; White, WB; Williams, G; Wittes, J; Zanchetti, A; Fakouhi, TD; Anders, RJ
   Baseline characteristics and early blood pressure control in the CONVINCE trial
   HYPERTENSION
   
   H.R. Black et al., "Baseline characteristics and early blood pressure control in the CONVINCE trial", HYPERTENSIO, 37(1), 2001, pp. 12-18
5. Grimm, RH; Margolis, KL; Papademetriou, V; Cushman, WC; Ford, CE; Bettencourt, J; Alderman, MH; Basile, JN; Black, HR; DeQuattro, V; Eckfeldt, J; Hawkins, CM; Perry, HM; Proschan, M
   Baseline characteristics of participants in the Antihypertensive and LipidLowering Treatment to Prevent Heart Attack Trial (ALLHAT)
   HYPERTENSION
   
   R.H. Grimm et al., "Baseline characteristics of participants in the Antihypertensive and LipidLowering Treatment to Prevent Heart Attack Trial (ALLHAT)", HYPERTENSIO, 37(1), 2001, pp. 19-27
6. Vaccarino, V; Berger, AK; Abramson, J; Black, HR; Setaro, JF; Davey, JA; Krumholz, HM
   Pulse pressure and risk of cardiovascular events in the systolic hypertension in the elderly program
   AMERICAN JOURNAL OF CARDIOLOGY
   
   V. Vaccarino et al., "Pulse pressure and risk of cardiovascular events in the systolic hypertension in the elderly program", AM J CARD, 88(9), 2001, pp. 980-986
7. White, WB; Johnson, MF; Anders, RJ; Elliott, WJ; Black, HR
   Safety of control led-onset extended-release verapamil in middle-aged and older patients with hypertension and coronary artery disease
   AMERICAN HEART JOURNAL
   
   W.B. White et al., "Safety of control led-onset extended-release verapamil in middle-aged and older patients with hypertension and coronary artery disease", AM HEART J, 142(6), 2001, pp. 1010-1015
8. Elliott, WJ; Black, HR; Neaton, JD; Grandits, G; Fakouhi, TD
   The Controlled ONset Verapamil INvestigation of Cardiovascular Endpoints (CONVINCE) trial
   CLINICAL TRIALS IN HYPERTENSION
   
   W.J. Elliott et al., "The Controlled ONset Verapamil INvestigation of Cardiovascular Endpoints (CONVINCE) trial", CLINICAL TRIALS IN HYPERTENSION, 2001, pp. 509-529
9. Black, HR
   Studies justifying the use of treatment to prevent cardiovascular events
   HYPERTENSION MEDICINE
   
   H.R. Black, "Studies justifying the use of treatment to prevent cardiovascular events", CUR CL PRAC, 2001, pp. 3-19
10. Black, HR; Sollins, JS; Garofalo, JL
    The addition of doxazosin to the therapeutic regimen of hypertensive patients inadequately controlled with other antihypertensive medications: A randomized, placebo-controlled study
    AMERICAN JOURNAL OF HYPERTENSION
    
    H.R. Black et al., "The addition of doxazosin to the therapeutic regimen of hypertensive patients inadequately controlled with other antihypertensive medications: A randomized, placebo-controlled study", AM J HYPERT, 13(5), 2000, pp. 468-474
11. Wassertheil-Smoller, S; Anderson, G; Psaty, BM; Black, HR; Manson, J; Wong, N; Francis, J; Grimm, R; Kotchen, T; Langer, R; Lasser, N
    Hypertension and its treatment in postmenopausal women - Baseline data from the Women's Health Initiative
    HYPERTENSION
    
    S. Wassertheil-Smoller et al., "Hypertension and its treatment in postmenopausal women - Baseline data from the Women's Health Initiative", HYPERTENSIO, 36(5), 2000, pp. 780-789
12. Izzo, JL; Levy, D; Black, HR
    Importance of systolic blood pressure in older Americans
    HYPERTENSION
    
    J.L. Izzo et al., "Importance of systolic blood pressure in older Americans", HYPERTENSIO, 35(5), 2000, pp. 1021-1024
13. Elliott, WJ; Weir, DR; Black, HR
    Cost-effectiveness of the lower treatment goal (of JNC VI) for diabetic hypertensive patients
    ARCHIVES OF INTERNAL MEDICINE
    
    W.J. Elliott et al., "Cost-effectiveness of the lower treatment goal (of JNC VI) for diabetic hypertensive patients", ARCH IN MED, 160(9), 2000, pp. 1277-1283
14. Wassertheil-Smoller, S; Fann, C; Allman, RM; Black, HR; Camel, GH; Davis, B; Masaki, K; Pressel, S; Prineas, RJ; Stamler, J; Vogt, TM
    Relation of low body mass to death and stroke in the systolic hypertensionin the elderly program
    ARCHIVES OF INTERNAL MEDICINE
    
    S. Wassertheil-Smoller et al., "Relation of low body mass to death and stroke in the systolic hypertensionin the elderly program", ARCH IN MED, 160(4), 2000, pp. 494-500
15. Black, HR; Jacobson, EJ
    Angiotensin receptor blockers: Their current and future place in clinical practice
    FORMULARY
    
    H.R. Black e E.J. Jacobson, "Angiotensin receptor blockers: Their current and future place in clinical practice", FORMULARY, 34(11), 1999, pp. 943
16. Black, HR
    A chronotherapeutic approach to the management of high-risk patients with hypertension ischemic heart disease - Introduction
    AMERICAN JOURNAL OF HYPERTENSION
    
    H.R. Black, "A chronotherapeutic approach to the management of high-risk patients with hypertension ischemic heart disease - Introduction", AM J HYPERT, 12(2), 1999, pp. 33S-34S
17. Black, HR
    Will better-tolerated antihypertensive agents improve blood pressure control? JNC VI revisited
    AMERICAN JOURNAL OF HYPERTENSION
    
    H.R. Black, "Will better-tolerated antihypertensive agents improve blood pressure control? JNC VI revisited", AM J HYPERT, 12(12), 1999, pp. 225S-230S
18. Black, HR
    Optimal blood pressure: How low should we go?
    AMERICAN JOURNAL OF HYPERTENSION
    
    H.R. Black, "Optimal blood pressure: How low should we go?", AM J HYPERT, 12(11), 1999, pp. 113S-120S
19. Black, HR; Zanchetti, A
    Reports of the Systolic and Pulse Pressure (SYPP) Working Group - First meeting of the SYPP Working Group - April 1999 Rome, Italy - Introduction
    JOURNAL OF HYPERTENSION
    
    H.R. Black e A. Zanchetti, "Reports of the Systolic and Pulse Pressure (SYPP) Working Group - First meeting of the SYPP Working Group - April 1999 Rome, Italy - Introduction", J HYPERTENS, 17, 1999, pp. S1-S1
20. Black, HR; Kuller, LH; O'Rourke, MF; Weber, MA; Alderman, MH; Benetos, A; Burnett, J; Cohn, JN; Franklin, SS; Mancia, G; Safar, M; Zanchetti, A
    The first report of the Systolic and Pulse Pressure (SYPP) Working Group
    JOURNAL OF HYPERTENSION
    
    H.R. Black et al., "The first report of the Systolic and Pulse Pressure (SYPP) Working Group", J HYPERTENS, 17, 1999, pp. S3-S14
21. Black, HR
    Isolated systolic hypertension in the elderly: lessons from clinical trials and future directions
    JOURNAL OF HYPERTENSION
    
    H.R. Black, "Isolated systolic hypertension in the elderly: lessons from clinical trials and future directions", J HYPERTENS, 17, 1999, pp. S49-S54
22. Black, HR
    The paradigm has shifted, to systolic blood pressure
    HYPERTENSION
    
    H.R. Black, "The paradigm has shifted, to systolic blood pressure", HYPERTENSIO, 34(3), 1999, pp. 386-387
23. Black, HR
    Valsartan hydrochlorothiazide
    DRUGS
    
    H.R. Black, "Valsartan hydrochlorothiazide", DRUGS, 57(5), 1999, pp. 756-757
24. Liebson, PR; Black, HR
    Hypertension - Diagnosis and treatment
    RESOURCE UTILIZATION IN CARDIAC DISEASE
    
    P.R. Liebson e H.R. Black, "Hypertension - Diagnosis and treatment", DEV CARD M, 216, 1999, pp. 127-147
25. SHEPS SG; BLACK HR; COHEN JD; KAPLAN N; FERDINAND KC
    THE 6TH REPORT OF THE JOINT NATIONAL COMMITTEE ON THE DETECTION, EVALUATION, AND TREATMENT OF HIGH BLOOD-PRESSURE
    American journal of managed care
    
    S.G. Sheps et al., "THE 6TH REPORT OF THE JOINT NATIONAL COMMITTEE ON THE DETECTION, EVALUATION, AND TREATMENT OF HIGH BLOOD-PRESSURE", American journal of managed care, 4(7), 1998, pp. 366-370
26. BLACK HR; YANKASKAS JR; JOHNSON LG; NOAH TL
    INTERLEUKIN-8 PRODUCTION BY CYSTIC-FIBROSIS NASAL EPITHELIAL-CELLS AFTER TUMOR-NECROSIS-FACTOR-ALPHA AND RESPIRATORY SYNCYTIAL VIRUS STIMULATION
    American journal of respiratory cell and molecular biology
    
    H.R. Black et al., "INTERLEUKIN-8 PRODUCTION BY CYSTIC-FIBROSIS NASAL EPITHELIAL-CELLS AFTER TUMOR-NECROSIS-FACTOR-ALPHA AND RESPIRATORY SYNCYTIAL VIRUS STIMULATION", American journal of respiratory cell and molecular biology, 19(2), 1998, pp. 210-215
27. Benz, JR; Black, HR; Graff, A; Reed, A; Fitzsimmons, S; Shi, Y
    Valsartan and hydrochlorothiazide in patients with essential hypertension.A multiple dose, double-blind, placebo controlled trial comparing combination therapy with monotherapy
    JOURNAL OF HUMAN HYPERTENSION
    
    J.R. Benz et al., "Valsartan and hydrochlorothiazide in patients with essential hypertension.A multiple dose, double-blind, placebo controlled trial comparing combination therapy with monotherapy", J HUM HYPER, 12(12), 1998, pp. 861-866
28. BLACK HR; CROCITTO MT
    NUMBER NEEDED TO TREAT - SOLID SCIENCE OR A PATH TO PERNICIOUS RATIONING
    American journal of hypertension
    
    H.R. Black e M.T. Crocitto, "NUMBER NEEDED TO TREAT - SOLID SCIENCE OR A PATH TO PERNICIOUS RATIONING", American journal of hypertension, 11(8), 1998, pp. 128-134
29. MOSER M; MCCOMBS JS; CUSHMAN; BLACK HR; MATERSON B; JACKSON
    PANEL DISCUSSION 2
    American journal of hypertension
    
    M. Moser et al., "PANEL DISCUSSION 2", American journal of hypertension, 11(8), 1998, pp. 135-137
30. MOSER M; BLACK HR
    THE ROLE OF COMBINATION THERAPY IN THE TREATMENT OF HYPERTENSION
    American journal of hypertension
    
    M. Moser e H.R. Black, "THE ROLE OF COMBINATION THERAPY IN THE TREATMENT OF HYPERTENSION", American journal of hypertension, 11(6), 1998, pp. 73-78
31. BLACK HR
    INDIVIDUALIZED SELECTION OF ANTIHYPERTENSIVE DRUG-THERAPY FOR OLDER PATIENTS
    American journal of hypertension
    
    H.R. Black, "INDIVIDUALIZED SELECTION OF ANTIHYPERTENSIVE DRUG-THERAPY FOR OLDER PATIENTS", American journal of hypertension, 11(3), 1998, pp. 62-67
32. BLACK HR
    ANTIHYPERTENSIVE THERAPY AND CARDIOVASCULAR-DISEASE - IMPACT OF EFFECTIVE THERAPY ON DISEASE PROGRESSION
    American journal of hypertension
    
    H.R. Black, "ANTIHYPERTENSIVE THERAPY AND CARDIOVASCULAR-DISEASE - IMPACT OF EFFECTIVE THERAPY ON DISEASE PROGRESSION", American journal of hypertension, 11(1), 1998, pp. 3-8
33. WHITE WB; JOHNSON M; BLACK HR; ELLIOTT WJ; FAKOUHI TD
    IMPACT OF CHRONOTHERAPEUTIC VERSUS HOMEOSTATIC THERAPY ON NOCTURNAL BLOOD-PRESSURE IN PATIENTS WITH HYPERTENSION
    Journal of hypertension
    
    W.B. White et al., "IMPACT OF CHRONOTHERAPEUTIC VERSUS HOMEOSTATIC THERAPY ON NOCTURNAL BLOOD-PRESSURE IN PATIENTS WITH HYPERTENSION", Journal of hypertension, 16, 1998, pp. 31107-31107
34. BLACK HR; ELLIOTT WJ; NEATON JD; GRANDITS G; GRAMBSCH P; GRIMM RH; HANSSON L; LACOUCIERE Y; MULLER J; SLEIGHT P; WEBER MA; WHITE WB; WILLIAMS G; WITTES J; ZANCHETTI A; FAKOUHI TD
    RATIONALE AND DESIGN FOR THE CONTROLLED ONSET VERAPAMIL INVESTIGATIONOF CARDIOVASCULAR END-POINTS (CONVINCE) TRIAL
    Controlled clinical trials
    
    H.R. Black et al., "RATIONALE AND DESIGN FOR THE CONTROLLED ONSET VERAPAMIL INVESTIGATIONOF CARDIOVASCULAR END-POINTS (CONVINCE) TRIAL", Controlled clinical trials, 19(4), 1998, pp. 370-390
35. SAVAGE PJ; PRESSEL SL; CURB JD; SCHRON EB; APPLEGATE WB; BLACK HR; COHEN J; DAVIS BR; FROST P; SMITH W; GONZALEZ N; GUTHRIE GP; OBERMAN A; RUTAN G; PROBSTFIELD JL; STAMLER J
    INFLUENCE OF LONG-TERM, LOW-DOSE, DIURETIC-BASED, ANTIHYPERTENSIVE THERAPY ON GLUCOSE, LIPID, URIC-ACID, AND POTASSIUM LEVELS IN OLDER MEN AND WOMEN WITH ISOLATED SYSTOLIC HYPERTENSION - THE SYSTOLIC HYPERTENSION IN THE ELDERLY PROGRAM
    Archives of internal medicine
    
    P.J. Savage et al., "INFLUENCE OF LONG-TERM, LOW-DOSE, DIURETIC-BASED, ANTIHYPERTENSIVE THERAPY ON GLUCOSE, LIPID, URIC-ACID, AND POTASSIUM LEVELS IN OLDER MEN AND WOMEN WITH ISOLATED SYSTOLIC HYPERTENSION - THE SYSTOLIC HYPERTENSION IN THE ELDERLY PROGRAM", Archives of internal medicine, 158(7), 1998, pp. 741-751
36. BLACK HR
    THE 6TH REPORT OF THE JOINT NATIONAL COMMITTEE ON PREVENTION, DETECTION, EVALUATION, AND TREATMENT OF HIGH BLOOD-PRESSURE (VOL 157, PG 2413, 1997)
    Archives of internal medicine
    
    H.R. Black, "THE 6TH REPORT OF THE JOINT NATIONAL COMMITTEE ON PREVENTION, DETECTION, EVALUATION, AND TREATMENT OF HIGH BLOOD-PRESSURE (VOL 157, PG 2413, 1997)", Archives of internal medicine, 158(6), 1998, pp. 573-573
37. ISAACSOHN JL; MOSER M; STEIN EA; DUDLEY K; DAVEY JA; LISKOV E; BLACK HR
    GARLIC POWDER AND PLASMA-LIPIDS AND LIPOPROTEINS - A MULTICENTER, RANDOMIZED, PLACEBO-CONTROLLED TRIAL
    Archives of internal medicine
    
    J.L. Isaacsohn et al., "GARLIC POWDER AND PLASMA-LIPIDS AND LIPOPROTEINS - A MULTICENTER, RANDOMIZED, PLACEBO-CONTROLLED TRIAL", Archives of internal medicine, 158(11), 1998, pp. 1189-1194
38. WHITE WB; BLACK HR; WEBER MA; ELLIOTT WJ; BRYZINSKI B; FAKOUHI TD
    COMPARISON OF EFFECTS OF CONTROLLED ONSET EXTENDED-RELEASE VERAPAMIL AT BEDTIME AND NIFEDIPINE GASTROINTESTINAL THERAPEUTIC SYSTEM ON ARISING ON EARLY-MORNING BLOOD-PRESSURE, HEART-RATE, AND THE HEART-RATE BLOOD-PRESSURE PRODUCT
    The American journal of cardiology
    
    W.B. White et al., "COMPARISON OF EFFECTS OF CONTROLLED ONSET EXTENDED-RELEASE VERAPAMIL AT BEDTIME AND NIFEDIPINE GASTROINTESTINAL THERAPEUTIC SYSTEM ON ARISING ON EARLY-MORNING BLOOD-PRESSURE, HEART-RATE, AND THE HEART-RATE BLOOD-PRESSURE PRODUCT", The American journal of cardiology, 81(4), 1998, pp. 424-431
39. BLACK HR
    NEW CONCEPTS IN HYPERTENSION - FOCUS ON THE ELDERLY
    The American heart journal
    
    H.R. Black, "NEW CONCEPTS IN HYPERTENSION - FOCUS ON THE ELDERLY", The American heart journal, 135(2), 1998, pp. 2-7
40. BLACK HR; GRAFF A; SHUTE D; STOLTZ R; RUFF D; LEVINE J; SHI Y; MALLOWS S
    VALSARTAN, A NEW ANGIOTENSIN-II ANTAGONIST FOR THE TREATMENT OF ESSENTIAL-HYPERTENSION - EFFICACY, TOLERABILITY AND SAFETY COMPARED TO AN ANGIOTENSIN-CONVERTING ENZYME-INHIBITOR, LISINOPRIL
    Journal of human hypertension
    
    H.R. Black et al., "VALSARTAN, A NEW ANGIOTENSIN-II ANTAGONIST FOR THE TREATMENT OF ESSENTIAL-HYPERTENSION - EFFICACY, TOLERABILITY AND SAFETY COMPARED TO AN ANGIOTENSIN-CONVERTING ENZYME-INHIBITOR, LISINOPRIL", Journal of human hypertension, 11(8), 1997, pp. 483-489
41. ELLIOTT WJ; BLACK HR
    RATIONALE AND BENEFITS OF CLASSIFICATION OF HYPERTENSION SEVERITY
    Current opinion in cardiology
    
    W.J. Elliott e H.R. Black, "RATIONALE AND BENEFITS OF CLASSIFICATION OF HYPERTENSION SEVERITY", Current opinion in cardiology, 12(4), 1997, pp. 368-374
42. BLACK HR; YI JY
    ROLES OF SYSTOLIC AND PULSE PRESSURES - RESPONSE
    Hypertension
    
    H.R. Black e J.Y. Yi, "ROLES OF SYSTOLIC AND PULSE PRESSURES - RESPONSE", Hypertension, 30(1), 1997, pp. 147-147
43. KOSTIS JB; DAVIS BR; CUTLER J; GRIMM RH; BERGE KG; COHEN JD; LACY CR; PERRY HM; BLAUFOX MD; WASSERTHEILSMOLLER S; BLACK HR; SCHRON E; BERKSON DM; CURB JD; SMITH WM; MCDONALD R; APPLEGATE WB
    PREVENTION OF HEART-FAILURE BY ANTIHYPERTENSIVE DRUG-TREATMENT IN OLDER PERSONS WITH ISOLATED SYSTOLIC HYPERTENSION
    JAMA, the journal of the American Medical Association
    
    J.B. Kostis et al., "PREVENTION OF HEART-FAILURE BY ANTIHYPERTENSIVE DRUG-TREATMENT IN OLDER PERSONS WITH ISOLATED SYSTOLIC HYPERTENSION", JAMA, the journal of the American Medical Association, 278(3), 1997, pp. 212-216
44. NOAH TL; BLACK HR; CHENG PW; WOOD RE; LEIGH MW
    NASAL AND BRONCHOALVEOLAR LAVAGE FLUID CYTOKINES IN EARLY CYSTIC-FIBROSIS
    The Journal of infectious diseases
    
    T.L. Noah et al., "NASAL AND BRONCHOALVEOLAR LAVAGE FLUID CYTOKINES IN EARLY CYSTIC-FIBROSIS", The Journal of infectious diseases, 175(3), 1997, pp. 638-647
45. GRIMM RH; DAVIS BR; FORD C; ALDERMAN MH; BLACK HR; CUSHMAN WC; DEQUATTRO V; PAPADEMETRIOU V
    THE ANTIHYPERTENSIVE AND LIPID-LOWERING TREATMENT TO PREVENT HEART-ATTACK TRIAL (ALLHAT) - THE LARGEST HYPERTENSION STUDY EVER UNDERTAKEN -BASE-LINE CHARACTERISTICS
    Circulation
    
    R.H. Grimm et al., "THE ANTIHYPERTENSIVE AND LIPID-LOWERING TREATMENT TO PREVENT HEART-ATTACK TRIAL (ALLHAT) - THE LARGEST HYPERTENSION STUDY EVER UNDERTAKEN -BASE-LINE CHARACTERISTICS", Circulation, 96(8), 1997, pp. 1542-1542
46. WHITE WB; MEHROTRA D; SEARLE GD; BLACK HR; FAKOUHI TD
    THE IMPORTANCE OF REGRESSION TO THE MEAN WHEN EVALUATING CIRCADIAN BLOOD-PRESSURE IN AN ANTIHYPERTENSIVE DRUG TRIAL
    Circulation
    
    W.B. White et al., "THE IMPORTANCE OF REGRESSION TO THE MEAN WHEN EVALUATING CIRCADIAN BLOOD-PRESSURE IN AN ANTIHYPERTENSIVE DRUG TRIAL", Circulation, 96(8), 1997, pp. 1883-1883
47. BLACK HR; COHEN JD; KAPLAN NM; FERDINAND KC; CHOBANIAN AV; DUSTAN HP; GIFFORD RW; MOSER M; SHEPS SG; AGODOA L; AUGUST PA; BAKRIS GL; BURT V; BUSSE W; CARTER BL; CHESLEY FD; CLEEMAN J; COHN JN; CREGLER LL; CRESPO C; CUSHMAN WC; CUTLER J; DARROW MD; DEQUATTRO VL; DEVEREUX RB; DWORKIN LD; ELLIOTT WJ; EPSTEIN M; FALKNER B; FERRARIO CM; FLACK JM; FRISHMAN W; FROHLICH ED; GREEN LA; GRIMM RH; HAGBERG JM; HALL WD; HANDLER J; HAVAS S; HILL MN; HORAN MJ; HSUEH WA; HYMAN BN; IZZO JL; JAMERSON K; KILEY JP; KOCHAR MS; KOLASA KM; KRAKOFF LR; LEVY D; LINDHEIMER MD; LUEPKER RV; MALONE MEL; MASSIE B; MATERSON BJ; MERCHANT J; MESSERLI FH; MILLER NH; MOORE MA; MUSTONEALEXANDER L; OPARIL S; PERRY HM; PICKERING TG; PRATT JH; RAM CVS; RANDALL OS; REED JW; ROBERTS RW; ROCCELLA EJ; ROGUS SD; SAUNDERS E; SCHRON E; SCHWARTZ G; SIBAI BM; SNYDER D; SOWERS JR; STAMLER J; TEMPLE R; TEXTOR S; THOM T; VIDT DG; WEBER M; WEINBERGER MH; WEINSHILBOUM R; WHELTON PK; WHISNANT JP; WIEBERS DO; WINSTON MC; WRIGHT JT; LENFANT C; CASSER L; COLMAN PJ; EDWARDS T; FEELEY DM; GAJEWSKI J; LEVINE D; MANGER W; MARSHALL EC; NICKEY WA; ROBERT RW; SECREST BG; SINGER EH; WHISNANT JP; WILSON GJ; YOUNG JM; BACHMAN JW; CAMPESE VM; CARR AA; HAND M; HOLDEN DC; JAMIESON MJ; JULIUS S; MENSAH GA; PRISANT M; SULLIVAN JM; WILSON DJ; MOROSCO G; ANDERSON DE; WAUGH D
    THE 6TH REPORT OF THE ,-EVALUATION,-AND-TREATMENT-OF-HIGH-BLOOD-PRESSURE
    Archives of internal medicine
    
    H.R. Black et al., "THE 6TH REPORT OF THE ,-EVALUATION,-AND-TREATMENT-OF-HIGH-BLOOD-PRESSURE", Archives of internal medicine, 157(21), 1997, pp. 2413-2446
48. WHITE WB; MEHROTRA DV; BLACK HR; FAKOUHI TD; ELLIOTT W; BYNNY RL; CARR AA; PRISANT M; GRIMM RH; HOGAN LB; KAIHLANEN PM; LEWIN A; MAXWELL MH; MERSEY JH; PRATT JH; PUNZI HA; ROSEN JB; SICA D; RIPLEY B; WALLIN JD; WEIDLER DJ; ESAYAGTENDER B
    EFFECTS OF CONTROLLED-ONSET EXTENDED-RELEASE VERAPAMIL ON NOCTURNAL BLOOD-PRESSURE (DIPPERS VERSUS NONDIPPERS)
    The American journal of cardiology
    
    W.B. White et al., "EFFECTS OF CONTROLLED-ONSET EXTENDED-RELEASE VERAPAMIL ON NOCTURNAL BLOOD-PRESSURE (DIPPERS VERSUS NONDIPPERS)", The American journal of cardiology, 80(4), 1997, pp. 469-474
49. SMITH DHG; NEUTEL JM; BLACK HR; SCHOENBERGER JA; WEBER MA
    ONCE-DAILY MONOTHERAPY WITH TRANDOLAPRIL IN THE TREATMENT OF HYPERTENSION
    Journal of human hypertension
    
    D.H.G. Smith et al., "ONCE-DAILY MONOTHERAPY WITH TRANDOLAPRIL IN THE TREATMENT OF HYPERTENSION", Journal of human hypertension, 10(2), 1996, pp. 129-134
50. DEY HM; SOUFER R; HOFFER P; WACKERS FJT; BLACK HR
    COMPARISON OF NIFEDIPINE GITS AND HYDROCHLOROTHIAZIDE IN THE MANAGEMENT OF ELDERLY PATIENTS WITH STAGE I-III DIASTOLIC HYPERTENSION
    American journal of hypertension
    
    H.M. Dey et al., "COMPARISON OF NIFEDIPINE GITS AND HYDROCHLOROTHIAZIDE IN THE MANAGEMENT OF ELDERLY PATIENTS WITH STAGE I-III DIASTOLIC HYPERTENSION", American journal of hypertension, 9(6), 1996, pp. 598-606
51. BLACK HR
    THE EMERGING ROLE OF CHRONOTHERAPEUTICS IN MANAGING HYPERTENSION - INTRODUCTION
    American journal of hypertension
    
    H.R. Black, "THE EMERGING ROLE OF CHRONOTHERAPEUTICS IN MANAGING HYPERTENSION - INTRODUCTION", American journal of hypertension, 9(4), 1996, pp. 1-1
52. BLACK HR
    THE CORONARY-ARTERY DISEASE PARADOX
    American journal of hypertension
    
    H.R. Black, "THE CORONARY-ARTERY DISEASE PARADOX", American journal of hypertension, 9(4), 1996, pp. 2-10
53. BLACK HR; SMOLENSKY MH; JOHNSTONE MT; WHITE WB
    THE EMERGING ROLE OF CHRONOTHERAPEUTICS IN MANAGING HYPERTENSION - PANEL DISCUSSION
    American journal of hypertension
    
    H.R. Black et al., "THE EMERGING ROLE OF CHRONOTHERAPEUTICS IN MANAGING HYPERTENSION - PANEL DISCUSSION", American journal of hypertension, 9(4), 1996, pp. 34-39
54. DAVIS BR; CUTLER JA; GORDON DJ; FURBERG CD; WRIGHT JT; CUSHMAN WC; GRIMM RH; LAROSA J; WHELTON PK; PERRY HM; ALDERMAN MH; FORD CE; OPARIL S; FRANCIS C; PROSCHAN M; PRESSEL S; BLACK HR; HAWKINS CM
    RATIONALE AND DESIGN FOR THE ANTIHYPERTENSIVE AND LIPID-LOWERING TREATMENT TO PREVENT HEART-ATTACK TRIAL (ALLHAT)
    American journal of hypertension
    
    B.R. Davis et al., "RATIONALE AND DESIGN FOR THE ANTIHYPERTENSIVE AND LIPID-LOWERING TREATMENT TO PREVENT HEART-ATTACK TRIAL (ALLHAT)", American journal of hypertension, 9(4), 1996, pp. 342-360
55. BLACK HR; YI JY
    NEW CLASSIFICATION SCHEME FOR HYPERTENSION BASED ON RELATIVE AND ABSOLUTE RISK WITH IMPLICATIONS FOR TREATMENT AND REIMBURSEMENT
    Hypertension
    
    H.R. Black e J.Y. Yi, "NEW CLASSIFICATION SCHEME FOR HYPERTENSION BASED ON RELATIVE AND ABSOLUTE RISK WITH IMPLICATIONS FOR TREATMENT AND REIMBURSEMENT", Hypertension, 28(5), 1996, pp. 719-724
56. SASEEN JJ; CARTER BL; BROWN TER; ELLIOTT WJ; BLACK HR
    COMPARISON OF NIFEDIPINE ALONE AND WITH DILTIAZEM OR VERAPAMIL IN HYPERTENSION
    Hypertension
    
    J.J. Saseen et al., "COMPARISON OF NIFEDIPINE ALONE AND WITH DILTIAZEM OR VERAPAMIL IN HYPERTENSION", Hypertension, 28(1), 1996, pp. 109-114
57. BLACK HR
    IMPROVING CARE OF PATIENTS WITH HYPERTENSION
    JAMA, the journal of the American Medical Association
    
    H.R. Black, "IMPROVING CARE OF PATIENTS WITH HYPERTENSION", JAMA, the journal of the American Medical Association, 276(13), 1996, pp. 1036-1037
58. REITNAUER PJ; BLACK HR; LEIGH MW; AYLSWORTH AS
    A 3 GENERATION FAMILY WITH FEATURES OF LACRIMO-AURICULO-DENTO-DIGITALSYNDROME (LADD) AND SEVERE CHRONIC LUNG-DISEASE
    Pediatric research
    
    P.J. Reitnauer et al., "A 3 GENERATION FAMILY WITH FEATURES OF LACRIMO-AURICULO-DENTO-DIGITALSYNDROME (LADD) AND SEVERE CHRONIC LUNG-DISEASE", Pediatric research, 39(4), 1996, pp. 485-485
59. WHITE WB; ANDERS RJ; MACINTYRE JM; BLACK HR; SICA DA; BYNNY RL; CARR AA; GRIMM RH; HOGAN LB; KAIHLANEN PM; LEWIN A; MAXWELL MH; MERSEY JH; PRATT JH; PUNZI HA; ROSEN JB; WALLIN JD; WEIDLER DJ
    NOCTURNAL DOSING OF A NOVEL DELIVERY SYSTEM OF VERAPAMIL FOR SYSTEMICHYPERTENSION (VOL 76, PG 375, 1995)
    The American journal of cardiology
    
    W.B. White et al., "NOCTURNAL DOSING OF A NOVEL DELIVERY SYSTEM OF VERAPAMIL FOR SYSTEMICHYPERTENSION (VOL 76, PG 375, 1995)", The American journal of cardiology, 77(11), 1996, pp. 1030-1030
60. BLACK HR
    THE REPORT OF 5TH JOINT NATIONAL COMMITTEE ON THE DETECTION, EVALUATION, AND TREATMENT OF HIGH BLOOD-PRESSURE - A LOOSE CONSTRUCTIONIST VIEW
    American journal of hypertension
    
    H.R. Black, "THE REPORT OF 5TH JOINT NATIONAL COMMITTEE ON THE DETECTION, EVALUATION, AND TREATMENT OF HIGH BLOOD-PRESSURE - A LOOSE CONSTRUCTIONIST VIEW", American journal of hypertension, 8(3), 1995, pp. 331-333
61. WHITE WB; ANDERS RJ; MACINTYRE JM; BLACK HR; SICA DA; BYNNY RL; CARR AA; GRIMM RH; HOGAN LB; KAIHLANEN PM; LEWIN A; MAXWELL MH; MERSEY JH; PRATT JH; PUNZI HA; ROSEN JB; WALLIN JD; WEIDLER DJ
    NOCTURNAL DOSING OF A NOVEL DELIVERY SYSTEM OF VERAPAMIL FOR SYSTEMICHYPERTENSION
    The American journal of cardiology
    
    W.B. White et al., "NOCTURNAL DOSING OF A NOVEL DELIVERY SYSTEM OF VERAPAMIL FOR SYSTEMICHYPERTENSION", The American journal of cardiology, 76(5), 1995, pp. 375-380
62. WOODWORTH JR; NYHART EH; WOLNY JD; BRIER GL; BLACK HR
    TOBRAMYCIN AND DAPTOMYCIN DISPOSITION WHEN CO-ADMINISTERED TO HEALTHY-VOLUNTEERS
    Journal of antimicrobial chemotherapy
    
    J.R. Woodworth et al., "TOBRAMYCIN AND DAPTOMYCIN DISPOSITION WHEN CO-ADMINISTERED TO HEALTHY-VOLUNTEERS", Journal of antimicrobial chemotherapy, 33(3), 1994, pp. 655-659
63. BLACK HR; ALDERMAN MH; COOPER JK; CUTLER J; GOINS MK; HORAN MJ; HUTCHINS EC; MANN RJ; SCHRON E; WHELTON PK; ROCCELLA EJ; AMES MV; ANDERSON DE; BRITO GT
    NATIONAL HIGH BLOOD-PRESSURE EDUCATION-PROGRAM WORKING GROUP-REPORT ON HYPERTENSION IN THE ELDERLY
    Hypertension
    
    H.R. Black et al., "NATIONAL HIGH BLOOD-PRESSURE EDUCATION-PROGRAM WORKING GROUP-REPORT ON HYPERTENSION IN THE ELDERLY", Hypertension, 23(3), 1994, pp. 275-285
64. ISAACSOHN JL; SETARO JF; NICHOLAS C; DAVEY JA; DIOTALEVI LJ; CHRISTIANSON DS; LISKOV E; STEIN EA; BLACK HR
    EFFECTS OF LOVASTATIN THERAPY ON PLASMINOGEN-ACTIVATOR INHIBITOR-1 ANTIGEN LEVELS
    The American journal of cardiology
    
    J.L. Isaacsohn et al., "EFFECTS OF LOVASTATIN THERAPY ON PLASMINOGEN-ACTIVATOR INHIBITOR-1 ANTIGEN LEVELS", The American journal of cardiology, 74(7), 1994, pp. 735-737
65. DEY HM; HOFFER PB; LERNER E; ZUBAL IG; SETARO JF; BLACK HR
    QUANTITATIVE-ANALYSIS OF THE TECHNETIUM-99M-DTPA CAPTOPRIL RENOGRAM -CONTRIBUTION OF WASHOUT PARAMETERS TO THE DIAGNOSIS OF RENAL-ARTERY STENOSIS
    The Journal of nuclear medicine
    
    H.M. Dey et al., "QUANTITATIVE-ANALYSIS OF THE TECHNETIUM-99M-DTPA CAPTOPRIL RENOGRAM -CONTRIBUTION OF WASHOUT PARAMETERS TO THE DIAGNOSIS OF RENAL-ARTERY STENOSIS", The Journal of nuclear medicine, 34(9), 1993, pp. 1416-1419
66. POWELL LH; BLACK HR
    VITAMIN-E AND THE RISK OF CORONARY-DISEASE
    The New England journal of medicine
    
    L.H. Powell e H.R. Black, "VITAMIN-E AND THE RISK OF CORONARY-DISEASE", The New England journal of medicine, 329(19), 1993, pp. 1425-1425
67. STEIN PP; BLACK HR
    THE ROLE OF DIET IN THE GENESIS AND TREATMENT OF HYPERTENSION
    The Medical clinics of North America
    
    P.P. Stein e H.R. Black, "THE ROLE OF DIET IN THE GENESIS AND TREATMENT OF HYPERTENSION", The Medical clinics of North America, 77(4), 1993, pp. 831-841
68. DOHLMAN AW; BLACK HR; ROYALL JA
    EXPIRED BREATH HYDROGEN-PEROXIDE IS A MARKER OF ACUTE AIRWAY INFLAMMATION IN PEDIATRIC-PATIENTS WITH ASTHMA
    The American review of respiratory disease
    
    A.W. Dohlman et al., "EXPIRED BREATH HYDROGEN-PEROXIDE IS A MARKER OF ACUTE AIRWAY INFLAMMATION IN PEDIATRIC-PATIENTS WITH ASTHMA", The American review of respiratory disease, 148(4), 1993, pp. 955-960
69. BLACK HR
    AGE-RELATED ISSUES IN THE TREATMENT OF HYPERTENSION
    The American journal of cardiology
    
    H.R. Black, "AGE-RELATED ISSUES IN THE TREATMENT OF HYPERTENSION", The American journal of cardiology, 72(20), 1993, pp. 80000010-80000013